4D Path Co-founder and Chief Scientist Satabhisa Mukhopadhyay, PhD, MS recently participated in a fireside chat with Alva10 CEO and Founder Hannah Mamuszka. The discussion explored the ability to accelerate cancer diagnostics through the use of 4D Path’s novel scientific discovery that delivers more accurate, actionable results from a single whole slide H&E biopsy image in a fraction of the time used by current cancer diagnostic treatment methods.
Watch the video of the session from Precision Medicine Leaders Summit’s virtual series on precision diagnostics to learn more about the technical considerations for removing the need for NGS panels in oncology and replacing with a digital pathology solution for better, faster and more efficient pathways to patient management and pharmaceutical drug discovery at: